COVID-19 RAPID RESPONSE
Nasal Antigen Rapid Test Kit
Rapid Covid Tests Canada - Buy direct online
All COVID-19 Rapid Tests are Class II Medical devices and subject to final sale - Orders cannot be canceled or refunded once processed.
Bulk Rapid Antigen Test sales are for private consumption, not for resale unless the purchesor holds a valid Health Canada Registered Medical Device Enterprise License (MDEL), bulk orders for distribution without registered MDEL are prohibited.
For Bulk Orders of 1300 Tests or More - Click here
The Rapid ResponseTM COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care settings.
The Rapid ResponseTM COVID-19 Antigen Rapid Test Device is intended for use by trained laboratory personnel or health care professionals.
The Rapid ResponseTM COVID-19 Antigen Rapid Test Device detects SARS-CoV-2 viral antigens through visual interpretation of colour development. Anti-SARS-CoV-2 antibodies are immobilized on the test region of the nitrocellulose membrane.
Anti-SARS-CoV-2 antibodies conjugated to coloured particles are immobilized on the conjugated pad. A sample is added to the extraction buffer which is optimized to release the SARS-CoV-2 antigens from specimen.
(Ontario) USEFUL LINKS:
- Ontario Ministry of Health’s Guidelines for using the Rapid Response COVID-19 Antigen Tests Here
- Ontario Ministry of Health Training Video for COVID-19 Antigen Rapid Testing
- Ontario Ministry of Health COVID-19 Provincial Antigen Screening Program Onboarding Guide
- Ontario Ministry of Health COVID-19 Health System Response Materials
Fedex shipping applies to all Canadian Provinces, additional shipping fees apply to NT YT & NU. CLS is not responisble for lost or stolen packages - All FedEx deliveres will require signature.
Point of care use authorized for all CDN Provinces, available for asymotomatic screening to trained users in ON, BC & AB